You Position: Home > Paper

Recent advance in perampanel in treating special population with epilepsy

( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Journal of Neuromedicine
Issue:
2
DOI:
10.3760/cma.j.cn115354-20221124-00858
Key Word:
癫痫;吡仑帕奈;儿童患者;女性患者;老年患者;Epilepsy;Perampanel;Child patient;Female patient;Elderly patient

Abstract´╝Ü Perampanel, one of the third-generation antiseizure drugs, can non-competitively bind a-amino-3- hydroxyl-5-methyl-4-isoxazole-propionate receptor. It has been approved for both monotherapy and adjunctive treatment of patients≥4 years old with focal epilepsy (with or without secondary generalized seizures) in China. Researches on treatment of perampanel in special population such as children, the elderly and women have been constantly updated, but summaries on them are lacked recently. This review summarizes the latest clinical studies on the above-mentioned population, providing reasonable basis for clinicians.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn